These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37840452)

  • 1. Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis.
    Metry A; Pandor A; Ren S; Shippam A; Clowes M; Dark P; McMullan R; Stevenson M
    Health Technol Assess; 2023 Aug; 27(14):1-92. PubMed ID: 37840452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
    Fraser H; Gallacher D; Achana F; Court R; Taylor-Phillips S; Nduka C; Stinton C; Willans R; Gill P; Mistry H
    Health Technol Assess; 2020 Jun; 24(31):1-232. PubMed ID: 32605705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Jun; 25(39):1-74. PubMed ID: 34142943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.
    Stevenson M; Uttley L; Oakley JE; Carroll C; Chick SE; Wong R
    Health Technol Assess; 2020 Feb; 24(11):1-150. PubMed ID: 32122460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation.
    Hounsome J; Pilkington G; Mahon J; Boland A; Beale S; Kotas E; Renton T; Dickson R
    Health Technol Assess; 2020 Jun; 24(30):1-116. PubMed ID: 32589125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis.
    Brazzelli M; Aucott L; Aceves-Martins M; Robertson C; Jacobsen E; Imamura M; Poobalan A; Manson P; Scotland G; Kaye C; Sawhney S; Boyers D
    Health Technol Assess; 2022 Jan; 26(7):1-286. PubMed ID: 35115079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.
    Fleeman N; Houten R; Nevitt S; Mahon J; Beale S; Boland A; Greenhalgh J; Edwards K; Maden M; Bhattacharyya D; Chaplin M; McEntee J; Chow S; Waddell T
    Health Technol Assess; 2024 Aug; 28(49):1-190. PubMed ID: 39252678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation.
    Westwood M; Ramaekers B; Grimm S; Worthy G; Fayter D; Armstrong N; Buksnys T; Ross J; Joore M; Kleijnen J
    Health Technol Assess; 2021 May; 25(33):1-276. PubMed ID: 34061019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
    Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
    Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation.
    Tikhonova IA; Yang H; Bello S; Salmon A; Robinson S; Hemami MR; Dodman S; Kharechko A; Haigh RC; Jani M; McDonald TJ; Hoyle M
    Health Technol Assess; 2021 Feb; 25(8):1-248. PubMed ID: 33555998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis.
    Horner DE; Davis S; Pandor A; Shulver H; Goodacre S; Hind D; Rex S; Gillett M; Bursnall M; Griffin X; Holland M; Hunt BJ; de Wit K; Bennett S; Pierce-Williams R
    Health Technol Assess; 2024 Apr; 28(20):1-166. PubMed ID: 38634415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prehospital continuous positive airway pressure for acute respiratory failure: the ACUTE feasibility RCT.
    Fuller GW; Keating S; Goodacre S; Herbert E; Perkins GD; Rosser A; Gunson I; Miller J; Ward M; Bradburn M; Thokala P; Harris T; Marsh MM; Scott AJ; Cooper C
    Health Technol Assess; 2021 Feb; 25(7):1-92. PubMed ID: 33538686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
    Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
    Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral nutritional interventions in frail older people who are malnourished or at risk of malnutrition: a systematic review.
    Thomson K; Rice S; Arisa O; Johnson E; Tanner L; Marshall C; Sotire T; Richmond C; O'Keefe H; Mohammed W; Gosney M; Raffle A; Hanratty B; McEvoy CT; Craig D; Ramsay SE
    Health Technol Assess; 2022 Dec; 26(51):1-112. PubMed ID: 36541454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation.
    Beese S; Avşar TS; Price M; Quinn D; Lim HS; Dretzke J; Ogwulu CO; Barton P; Jackson L; Moore D
    Health Technol Assess; 2024 Aug; 28(38):1-237. PubMed ID: 39189844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.